We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
-19.03%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$1.02B
AUM Growth
-$65M
Cap. Flow
+$173M
Cap. Flow %
17.05%
Top 10 Hldgs %
60.98%
Holding
215
New
14
Increased
69
Reduced
86
Closed
30

Sector Composition

Rank Sector Weight
1 Technology 4.09%
2 Financials 2.8%
3 Communication Services 2.05%
4 Healthcare 1.49%
5 Consumer Staples 0.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
76
Intel
INTC
$413B
$1.09M 0.11%
20,167
+1,626
+9% +$96.2K
MRK icon
77
Merck
MRK
$322B
$1.08M 0.11%
14,797
+984
+7% +$77.3K
CMCSA icon
78
Comcast
CMCSA
$87.3B
$1.07M 0.11%
31,088
+1,521
+5% +$64.2K
VTV icon
79
Vanguard Value ETF
VTV
$188B
$1.05M 0.1%
11,847
+2,140
+22% +$235K
QCOM icon
80
Qualcomm
QCOM
$164B
$1.02M 0.1%
15,148
-1,830
-11% -$150K
CWB icon
81
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.41B
$1.01M 0.1%
21,052
RTN
82
DELISTED
Raytheon Company
RTN
$955K 0.09%
7,279
-1,869
-20% -$370K
BSV icon
83
Vanguard Short-Term Bond ETF
BSV
$44.7B
$948K 0.09%
11,552
+405
+4% +$32.9K
HYG icon
84
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$891K 0.09%
11,573
-1,632
-12% -$138K
VV icon
85
Vanguard Large-Cap ETF
VV
$51.2B
$882K 0.09%
7,450
-337
-4% -$47.3K
IJR icon
86
iShares Core S&P Small-Cap ETF
IJR
$109B
$877K 0.09%
15,631
+2,201
+16% +$164K
ACWI icon
87
iShares MSCI ACWI ETF
ACWI
$32B
$842K 0.08%
13,449
+6,374
+90% +$472K
WFC icon
88
Wells Fargo
WFC
$254B
$833K 0.08%
28,954
-461
-2% -$19.6K
QEMM icon
89
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
$52.5M
$828K 0.08%
17,691
-3,602
-17% -$200K
KO icon
90
Coca-Cola
KO
$383B
$808K 0.08%
18,171
-1,025
-5% -$55.4K
FNDF icon
91
Schwab Fundamental International Large Company Index ETF
FNDF
$24.4B
$806K 0.08%
+38,302
New +$990K
PFE icon
92
Pfizer
PFE
$143B
$793K 0.08%
25,590
-1,577
-6% -$53.7K
MDY icon
93
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
$772K 0.08%
2,937
-181
-6% -$61.4K
BAC icon
94
Bank of America
BAC
$429B
$771K 0.08%
36,390
-1,040
-3% -$31.2K
ADBE icon
95
Adobe
ADBE
$105B
$752K 0.07%
2,364
-100
-4% -$34.2K
RSP icon
96
Invesco S&P 500 Equal Weight ETF
RSP
$97.3B
$752K 0.07%
8,947
-143
-2% -$15.2K
VGSH icon
97
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$749K 0.07%
12,004
+3,415
+40% +$210K
IFGL icon
98
iShares International Developed Real Estate ETF
IFGL
$82.8M
$739K 0.07%
34,137
-34,799
-50% -$964K
ESTC icon
99
Elastic
ESTC
$6.7B
$718K 0.07%
12,870
+8,574
+200% +$554K
SCHV
100
Schwab US Large-Cap Value ETF
SCHV
$15.6B
$708K 0.07%
48,057
-8,235
-15% -$151K

Similar funds

Aspiriant LLC's Q1 2020 Portfolio in Review

As of Q1 2020, Aspiriant LLC held 215 positions worth $1.02B, down 6% from $1.08B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Aspiriant LLC deployed $173M of net new capital in Q1 2020, opening 14 new positions and adding to 69 existing holdings. Its largest new stake was Vanguard Tax-Exempt Bond Index Fund: 78,455 shares worth $4.15M.

By sector, the portfolio is most concentrated in Technology at 4.1% of assets, down from 4.3% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $4.54M trimmed.

  • Aspiriant LLC's largest Q1 2020 buy was Vanguard Tax-Exempt Bond Index Fund: 78,455 shares worth $4.15M.
  • Aspiriant LLC added most to WisdomTree Emerging Markets High Dividend Fund in Q1 2020, an estimated $82.8M increase.
  • Aspiriant LLC's biggest Q1 2020 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.54M.
  • Aspiriant LLC fully exited Schwab US REIT ETF in Q1 2020, selling an estimated $1M.
  • Aspiriant LLC's ten largest holdings make up 61% of its $1.02B portfolio in Q1 2020.
  • Aspiriant LLC opened 14 new positions and closed 30 in Q1 2020.
  • Aspiriant LLC's portfolio value fell 6% quarter-over-quarter to $1.02B.

Based on Aspiriant LLC's 13F filing for Q1 2020, filed 5 May 2020.